- Home
- FOF vs SOPH Comparison
FOF vs SOPH Comparison
Compare FOF & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOF | SOPH |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 367.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FOF | SOPH |
|---|---|---|
| Price | $13.65 | $4.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 75.0K | ★ 109.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.16 |
| Revenue Next Year | N/A | $17.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.97 | $2.58 |
| 52 Week High | $15.04 | $5.70 |
Technical Indicators
Market Signals| Indicator | FOF | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 35.73 | 47.33 |
| Support Level | $12.87 | $4.54 |
| Resistance Level | $14.50 | $4.86 |
| Average True Range (ATR) | 0.19 | 0.29 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 3.41 | 59.79 |
Price Performance
Historical ComparisonAbout FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.